Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Principal Investigator: Paul Rufo, MD, MMSc
Trial Description: The purpose of this research is to study and compare the levels of Anti-Saccharomyces cerevisiae antibodies (ASCA) in both the blood and stool of pediatric patients diagnosed with Inflammatory Bowel Disease (IBD). ASCA levels will be compared with disease severity, disease duration, and immunoglobulin levels. The goal of this study is to discover new ways to help physicians diagnose and treat their patients with inflammatory bowel disease without relying on invasive testing.
Study Procedure: Participants in the study will be asked to provide both stool and blood samples during the initial study visit and again 3-6 months later. Blood samples will be drawn at the sample time as clinical labs and stool samples can be sent by mail.
Protocol Status: Open for recruitment
Compensation: Study participants will be given $10 for each stool sample provided.
Recruitment Info: Individuals 18 years or younger, who have been diagnosed with IBD or constipation.
Recruitment Contact Name: Rajat Moman, MS
Recruitment Contact Phone: (617) 355-2962
Recruitment Contact Email: firstname.lastname@example.org
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”